These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33197448)

  • 21. Correlation between cervical carcinogenesis and tobacco use by sexual partners.
    Siokos AG; Siokou-Siova O; Tzafetas I
    Hell J Nucl Med; 2019; 22 Suppl 2():184-190. PubMed ID: 31802062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect and mechanism of Magnolia officinalis in colorectal cancer: Multi-component-multi-target approach.
    Zhang H; Tang J; Cao H; Wang C; Shen C; Liu J
    J Ethnopharmacol; 2025 Feb; 338(Pt 1):119007. PubMed ID: 39471878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.
    Triana L; Palacios Huatuco RM; Campilgio G; Liscano E
    Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public engagement to refine a whole-school intervention to promote adolescent mental health.
    Bonell C; Hope S; Sundaram N; Lloyd-Houldey O; Michalopoulou S; Scott S; Nicholls D; Viner R
    Public Health Res (Southampt); 2024 Dec; ():1-22. PubMed ID: 39636228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer.
    Jung J; Kim NH; Park J; Lim D; Kwon M; Gil W; Jung S; Go M; Kim C; Cheong YH; Lee MH; Park HS; Eom YB; Park SA
    Breast Cancer Res; 2024 Nov; 26(1):174. PubMed ID: 39614338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
    Kramer N; Schmöllerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschläger M; Schüler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
    Oncogene; 2017 Sep; 36(39):5460-5472. PubMed ID: 28553956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.
    Roh ME; Gutman J; Murphy M; Hill J; Madanitsa M; Kakuru A; Barsosio HC; Kariuki S; Lusingu JPA; Mosha F; Kajubi R; Kamya MR; Mathanga D; Chinkhumba J; Laufer MK; Mlugu E; Kamuhabwa AAR; Aklillu E; Minzi O; Okoro RN; Geidam AD; Ohieku JD; Desai M; Jagannathan P; Dorsey G; Ter Kuile FO
    medRxiv; 2024 Nov; ():. PubMed ID: 39649586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Risk Genes S1PR5, CMC1, and ASAH1 as Potential Targets for the Diagnosis, Immunotherapy, and Treatment of Colon Adenocarcinoma by Single-Cell and Bulk RNA Sequencing Analysis.
    Xu Z; Gong J; Hu W; Ge C; Tong G; Cai F; Zhu Z; Yuan Y; Chen C
    Curr Med Chem; 2024 Nov; ():. PubMed ID: 39513308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells.
    Weber SM; Brossier NM; Prechtl A; Barnes S; Wilson LS; Brosius SN; Longo JF; Carroll SL
    Cell Commun Signal; 2021 Sep; 19(1):95. PubMed ID: 34530870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips.
    Manes TJ; DeGenova DT; Taylor BC; Patel JN
    JBJS Essent Surg Tech; 2024; 14(4):. PubMed ID: 39650795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PFAS promotes colorectal cancer progression via regulating RIG-I-mediated innate immune signalling.
    Ding C; Tao G; Chen G; Xie Y; Yang C; Qi S; Hou J; Jiang X; Deng X; Liao W
    Mol Immunol; 2024 Dec; 176():73-83. PubMed ID: 39586166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3-VISTA axis-based combination immunotherapy for APC truncation colorectal cancer.
    Wu L; Bai R; Zhang Y; Chen H; Wu J; Chen Z; Wang H; Zhao L
    J Immunother Cancer; 2024 Dec; 12(12):. PubMed ID: 39653551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis.
    Mei H; Luo Q; Weng J; Hao J; Cai J; Zhou R; Bian C; Ye Y; Luo S; Wen Y
    Cell Mol Biol Lett; 2024 Nov; 29(1):144. PubMed ID: 39587482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulated ITGB4 promotes hepatocellular carcinoma metastasis by activating hypoxia-mediated glycolysis and cancer-associated fibroblasts.
    Mai RY; Ye JZ; Gao X; Wen T; Li SZ; Zeng C; Cen WJ; Wu GB; Lin Y; Liang R; Luo XL
    Eur J Pharmacol; 2025 Jan; 986():177102. PubMed ID: 39603378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis.
    Zhang Z; Liu F; Yu Y; Xie F; Zhu T
    PeerJ; 2024; 12():e18530. PubMed ID: 39624133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.